(0.94%) 5 095.97 points
(0.22%) 38 168 points
(1.90%) 15 909 points
(0.07%) $83.63
(-1.71%) $1.610
(0.17%) $2 346.50
(-0.34%) $27.26
(0.38%) $924.00
(0.52%) $0.937
(0.88%) $11.05
(0.47%) $0.803
(-0.13%) $92.05
@ NOK34.00
Issued: 26 Apr 2024 @ 03:04
Return: 0.00%
Previous signal: Apr 25 - 10:13
Previous signal:
Return: -0.29 %
Live Chart Being Loaded With Signals
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics...
Stats | |
---|---|
Today's Volume | 4 319.00 |
Average Volume | 82 214.00 |
Market Cap | 592.72M |
EPS | NOK0.390 ( 2023-11-01 ) |
Next earnings date | ( NOK0 ) 2024-05-31 |
Last Dividend | NOK0.998 ( 2010-04-13 ) |
Next Dividend | NOK0 ( N/A ) |
P/E | 28.81 |
ATR14 | NOK0.800 (2.35%) |
Volume Correlation
Navamedic ASA Correlation
10 Most Positive Correlations | |
---|---|
NORSE.OL | 0.895 |
SMOP.OL | 0.871 |
NTEL.OL | 0.871 |
TOM.OL | 0.868 |
ENDUR.OL | 0.839 |
XXL.OL | 0.838 |
KIT.OL | 0.832 |
SNI.OL | 0.826 |
BORR.OL | 0.815 |
AYFIE.OL | 0.813 |
10 Most Negative Correlations | |
---|---|
AKBM.OL | -0.895 |
ODL.OL | -0.895 |
SCATC.OL | -0.893 |
SBX.OL | -0.87 |
OKEA.OL | -0.858 |
VOLUE.OL | -0.857 |
PHO.OL | -0.854 |
FRO.OL | -0.852 |
TRVX.OL | -0.846 |
XPLRA.OL | -0.842 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Navamedic ASA Correlation - Currency/Commodity
Navamedic ASA Financials
Annual | 2023 |
Revenue: | NOK512.00M |
Gross Profit: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2023 |
Revenue: | NOK512.00M |
Gross Profit: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2022 |
Revenue: | NOK382.14M |
Gross Profit: | NOK163.52M (42.79 %) |
EPS: | NOK1.750 |
FY | 2021 |
Revenue: | NOK278.44M |
Gross Profit: | NOK111.74M (40.13 %) |
EPS: | NOK0.00774 |
Financial Reports:
No articles found.
Navamedic ASA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
First Dividend | NOK0.998 | 2010-04-13 |
Last Dividend | NOK0.998 | 2010-04-13 |
Next Dividend | NOK0 | N/A |
Payout Date | 2010-04-27 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | NOK0.998 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.13 | -- |
Div. Sustainability Score | 5.91 | |
Div.Growth Potential Score | 1.583 | |
Div. Directional Score | 3.75 | -- |
Year | Amount | Yield |
---|---|---|
2010 | NOK0.998 | 17.80% |
2011 | NOK0 | 0.00% |
2012 | NOK0 | 0.00% |
2013 | NOK0 | 0.00% |
2014 | NOK0 | 0.00% |
2015 | NOK0 | 0.00% |
2016 | NOK0 | 0.00% |
2017 | NOK0 | 0.00% |
2018 | NOK0 | 0.00% |
2019 | NOK0 | 0.00% |
2020 | NOK0 | 0.00% |
2021 | NOK0 | 0.00% |
2022 | NOK0 | 0.00% |
2023 | NOK0 | 0.00% |
2024 | NOK0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ALNG.OL | Dividend King | 2023-11-27 | Quarterly | 2 | 6.60% | 7.04 |
OKEA.OL | Dividend Knight | 2023-12-01 | Quarterly | 3 | 5.65% | 6.86 |
SALM.OL | Dividend Knight | 2023-06-09 | Annually | 17 | 2.80% | 4.97 |
BWLPG.OL | Dividend Knight | 2023-11-17 | Quarterly | 11 | 1.68% | 4.46 |
ELK.OL | Dividend Knight | 2023-05-02 | Annually | 6 | 6.64% | 4.31 |
BWO.OL | Dividend Knight | 2023-11-20 | Quarterly | 14 | 0.87% | 3.96 |
ATEA.OL | Dividend Knight | 2023-11-20 | Annually | 16 | 2.97% | 3.45 |
HAFNI.OL | Dividend Knight | 2023-11-23 | Semi-Annually | 5 | 1.18% | 3.31 |
AKER.OL | Dividend Knight | 2023-11-07 | Semi-Annually | 20 | 2.99% | 3.13 |
AUSS.OL | Dividend Knight | 2023-05-26 | Annually | 17 | 3.23% | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00752 | 1.500 | 9.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00735 | 1.200 | 9.76 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0175 | 1.500 | -0.916 | -1.374 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.111 | 0.800 | 9.44 | 7.56 | [1 - 3] |
quickRatioTTM | 0.469 | 0.800 | -1.948 | -1.558 | [0.8 - 2.5] |
cashRatioTTM | 0.201 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.287 | -1.500 | 5.22 | -7.83 | [0 - 0.6] |
interestCoverageTTM | 2.30 | 1.000 | -0.260 | -0.260 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0898 | -0.180 | [0 - 20] |
debtEquityRatioTTM | 0.675 | -1.500 | 7.30 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.378 | 1.000 | 7.03 | 7.03 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0404 | 1.000 | -1.192 | -1.192 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00595 | 1.000 | -1.144 | -1.144 | [0.2 - 2] |
assetTurnoverTTM | 0.977 | 0.800 | 6.82 | 5.46 | [0.5 - 2] |
Total Score | 5.91 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 152.51 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0175 | 2.50 | -0.589 | -1.374 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0598 | -0.180 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 2.47 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00175 | 1.000 | -2.54 | 0 | [0.1 - 0.5] |
Total Score | 1.583 |
Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators